Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Based on the studies I've looked at I'd

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 541
Posts 24,585
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 9/30/2019 4:38:42 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/20/2019 4:36:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:34:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2019 4:52:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2019 4:51:57 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/13/2019 4:11:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/2/2019 4:29:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 9:30:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 10:16:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:19:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 7:33:24 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/10/2019 7:32:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2019 4:05:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/31/2019 4:18:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2019 4:17:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/22/2019 12:08:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2019 4:32:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2018 5:02:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:07:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:02:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 7:16:54 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2018 5:03:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/24/2018 7:01:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2018 4:17:40 PM
KarinCA Member Level  Saturday, 06/08/19 06:45:39 PM
Re: loanranger post# 265436
Post # of 274711 
Based on the studies I've looked at I'd definitely ask the question if I were still doing management interviews. But, not being privy to all of the same information they are dealing with I won't hazard a guess at which route would be better using Brilacidin. There appear to be pros and cons and, I'm a bit curious as to what makes/made the final decision.

A Thermo-sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509789/

Colon Targeted Drug Delivery Systems: A Review on Primary and Novel Approaches
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215502/

Comparative study of enema retention and preference in ulcerative colitis
https://pmj.bmj.com/content/81/959/594






In Reply to the following portion of 'loanranger' post
Quote:
If quicker is what you're looking for why not run the trial with the existing product?
I'm pretty sure you would ask that question if you were still doing management interviews.








To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist